Literature DB >> 11888491

An extensively hydrolysed cow's milk formula improves clinical symptoms of gastroesophageal reflux and reduces the gastric emptying time in infants.

A Garzi1, M Messina, F Frati, L Carfagna, L Zagordo, M Belcastro, S Parmiani, L Sensi, F Marcucci.   

Abstract

BACKGROUND: About 20 % of infants fed with breast-milk substitutes suffer from Gastro Esophageal Reflux (GER) and 1/3 of them also show Cow's Milk Allergy (CMA) symptoms.
METHODS: We planned this study to assess by dynamic echography the usefulness of an Extensively Hydrolysed Cow's Milk Formula (eHF) in infants suffering from GER. Ten infants showing GER symptoms and 10 normal babies, all fed with breast-milk substitutes, were enrolled. Clinical symptom scores related to GER were assessed for one week. The Gastric Emptying Time (GET) was determined by means of dynamic echography after feeding with cow's milk-derived formulae and again after a week feeding with eHF in subjects previously showing GER symptoms.
RESULTS: All infants with a clinical diagnosis for GER showed an abnormally high average GET in comparison to normal subjects (205 vs 124 min, p = 0.000). Switching to the eHF led to a significant clinical improvement (p = 0.0039) especially in babies skin-test and RAST positive to cow's milk, and to a significant decrease toward the normal value of the GET (167 min, p < 0.001).
CONCLUSIONS: The eHF tested improves GER symptoms in infants suffering from this disease. Our experience confirms and supports the use of dynamic echography as a reliable, simple, and non-invasive diagnostic method for infants with an increased GET associated with clinical symptoms of GER.

Entities:  

Mesh:

Year:  2002        PMID: 11888491     DOI: 10.1016/s0301-0546(02)79085-x

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  11 in total

1.  Esophagogastric dissociation reduces the re-operation rate for persistent gastroesophageal reflux in severely neurologically impaired children.

Authors:  F Molinaro; Edoardo Bindi; E Cerchia; R Angotti; F Mariscoli; M Messina
Journal:  Pediatr Surg Int       Date:  2014-08-20       Impact factor: 1.827

2.  Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.

Authors:  Angela Villiger; Cordula Stillhart; Neil Parrott; Martin Kuentz
Journal:  AAPS J       Date:  2016-04-08       Impact factor: 4.009

3.  Investigation of regurgitation and other symptoms of gastroesophageal reflux in Indonesian infants.

Authors:  Badriul Hegar; Aswitha Boediarso; Agus Firmansyah; Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

Review 4.  Systematic review of the impact of feed protein type and degree of hydrolysis on gastric emptying in children.

Authors:  Rosan Meyer; Ru-Xin Melanie Foong; Nikhil Thapar; Stamatiki Kritas; Neil Shah
Journal:  BMC Gastroenterol       Date:  2015-10-15       Impact factor: 3.067

Review 5.  Nonpharmacological management of gastroesophageal reflux in preterm infants.

Authors:  Luigi Corvaglia; Silvia Martini; Arianna Aceti; Santo Arcuri; Roberto Rossini; Giacomo Faldella
Journal:  Biomed Res Int       Date:  2013-09-01       Impact factor: 3.411

Review 6.  Influence of Food on Paediatric Gastrointestinal Drug Absorption Following Oral Administration: A Review.

Authors:  Hannah K Batchelor
Journal:  Children (Basel)       Date:  2015-06-09

Review 7.  Cow's Milk Allergy or Gastroesophageal Reflux Disease-Can We Solve the Dilemma in Infants?

Authors:  Silvia Salvatore; Massimo Agosti; Maria Elisabetta Baldassarre; Enza D'Auria; Licia Pensabene; Luana Nosetti; Yvan Vandenplas
Journal:  Nutrients       Date:  2021-01-21       Impact factor: 5.717

8.  Application effect of extensively hydrolyzed milk protein formula and follow-up in preterm children with a gestational age of less than 34 weeks: study protocol for a randomized controlled trial.

Authors:  Li-Ping Yin; Li-Juan Qian; Huan Zhu; Yan Chen; Han Li; Ji-Nan Han; Li-Xing Qiao
Journal:  Trials       Date:  2015-11-04       Impact factor: 2.279

9.  Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.

Authors:  Stefan Willmann; Corina Becker; Rolf Burghaus; Katrin Coboeken; Andrea Edginton; Jörg Lippert; Hans-Ulrich Siegmund; Kirstin Thelen; Wolfgang Mück
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

10.  Extensive protein hydrolysate formula effectively reduces regurgitation in infants with positive and negative challenge tests for cow's milk allergy.

Authors:  Y Vandenplas; E De Greef
Journal:  Acta Paediatr       Date:  2014-03-31       Impact factor: 2.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.